Active	Status	Sponsor type	Region	Phase	Filter
5 Active 5 Inactive 10 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Arun, Banu
NCT01471106: Phase II Short-term Adjuvant Therapy and Biomarker Studies With Targeted Agents in Women With Estrogen Receptor Negative Breast Cancer	Active, not recruiting	2	26	US	Dasatinib, BMS-354825, Sprycel	M.D. Anderson Cancer Center, Susan G. Komen Breast Cancer Foundation, Bristol-Myers Squibb	Breast Cancer	01/25	01/25